A letter in the BMJ

References:

  1. Davies J, Moncrieff J, Kinderman P, et al; Council for Evidence-Based Psychiatry. Stigma and efficacy of taking antidepressants. Letter to the editorTimes 2018 Feb 23.
  2. Burns W. Pills for depression. Letter to the editor. Times 2018
  3. Hengartner MP. Rapid response to: Adlington K, Pop a million happy pills? Antidepressants, nuance, and the media. BMJ 2018;360:k1069
  4. Davies J, Read J, Hengartner M, et al. Rapid response to: Iacobucci G, NHS prescribed record number of antidepressants last year. BMJ 2019;364:l1508
  5. National Institute for Health and Care Excellence. Depression in adults: recognition and management. 2009
  6. Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav2018;2018:4
  7. Perahia DG, Kajdasz DK, Desaiah D, Haddad PM. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. J Affect Disord2005;89:207-12.
  8. Zajecka J, Fawcett J, Amsterdam J, et al. Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study. J Clin Psychopharmacol1998;18:193-7.
  9. Royal College of Psychiatrists. Coming off antidepressants. 2012. (Accessed Feb 2018.)
  10. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci2000;25:255-61
  11. Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol1996;42:757-63
  12. Narayan V, Haddad PM. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria. J Psychopharmacol2011;25:306-13
  13. Davies J, Pauli R, Montagu L. Antidepressant withdrawal: a survey of patients’ experience by the All-Party Parliamentary Group for Prescribed Drug Dependence. 2018.
  14. Stockmann T, Odegbaro D, Timimi S, Moncrieff J. SSRI and SNRI withdrawal symptoms reported on an internet forum. Int J Risk Saf Med2018;29:175-80.
  15. Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Withdrawal symptoms after serotonin-noradrenaline reuptake Inhibitor discontinuation: systematic review. Psychother Psychosom2018;87:195-203
  16. Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J. Withdrawal symptoms after serotonin-noradrenaline reuptake Inhibitor discontinuation: systematic review. Psychother Psychosom2018;87:195-203
  17. Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav2018. doi:10.1016/j
  18. NHS Digital. Prescriptions dispensed in the communityStatistics for England, 2006-2016.
  19. Kendrick T. Long-term antidepressant treatment: Time for a review? Prescriber2015;26:7
  20. Davies J, Pauli G, Montagu L. A survey of antidepressant withdrawal reactions and their management in primary care. Report from the All Party Parliamentary Group for Prescribed Drug Dependence. 2018.
  21. Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence 2016;10:1401-7
  22.  J, Read, Cartwright C, Gibson K. How many of 1829 antidepressant users report withdrawal symptoms or addiction? Int J Ment Health Nurs 2018
  23. Read J, Williams J. Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects. Curr Drug Saf2018;13:176-86

 

2 Replies to “A letter in the BMJ”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.